Crystal Structure of the Catalytic Domain of HIV-1 Integrase: Similarity to Other Polynucleotidyl Transferases
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
HIV integrase is the enzyme responsible for inserting the viral DNA into the host chromosome; it is essential for HIV replication. The crystal structure of the catalytically active core domain (residues 50 to 212) of HIV-1 integrase was determined at 2.5 Å resolution. The central feature of the structure is a five-stranded β sheet flanked by helical regions. The overall topology reveals that this domain of integrase belongs to a superfamily of polynucleotidyl transferases that includes ribonuclease H and the Holliday junction resolvase RuvC. The active site region is identified by the position of two of the conserved carboxylate residues essential for catalysis, which are located at similar positions in ribonuclease H. In the crystal, two molecules form a dimer with an extensive solvent-inaccessible interface of 1300 Å 2 per monomer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All INs harbour three structural domains connected by flexible linkers: the N-terminal domain (NTD), the catalytic core domain (CCD), and the C-terminal domain (CTD).”
From Structure and function of retroviral integrase (2022) · cites this paper as [23]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures
Brünger, A. T. (1992) · Nature · doi:10.1038/355472a0 · Cited by 3,873
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Sparse matrix sampling: a screening method for crystallization of proteins
Jancarik, J., & Kim, S. H. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004430 · Cited by 2,049
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Research works printed but not linked: 5
- CROUCH, R.J., NEW BIOL 2: 771 (1990).
- Crouch, R. J., Nucleases: 211 (1982).
- Doublie, S., Crystallization of Nucleic Acids and Proteins: 311 (1992).
- Otwinowski,, Z., Data Collection and Processing: 56 (1993).
- Sherratt, D., Mobile DNA: 163 (1989).
Cited by
Items 301–400 of 842
van den Ent, F. M. I., Vos, A., & Plasterk, R. H. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3176-3183.1999 · Cited by 49
“Elucidation of the three-dimensional structure of the core of HIV-1 IN (16) and of avian sarcoma virus IN (3) revealed that IN is a member of a group of structurally related polynucleotidyl transferases (53, 76).”
BackgroundStructure-based HIV-1 integrase inhibitor design: a future perspective
Neamati, N. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.281 · Cited by 60
Assembly of phage Mu transpososomes: Cooperative transitions assisted by protein and DNA scaffolds
Mizuuchi, M., Baker, T. A., & Mizuuchi, K. (1995) · Cell · doi:10.1016/0092-8674(95)90115-9 · Cited by 49
Chaconas, G., & Harshey, R. M. (2007) · Wiley eBooks · doi:10.1128/9781555817954.ch17 · Cited by 48
Sluis‐Cremer, N., & Tachedjian, G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03216.x · Cited by 49
“However, the threedimensional structure of each domain has been solved [65–67] as have structures of two domain INs containing either the catalytic core and C-terminal domain [68], or the N-terminal domain and the catalytic core [69].”
Background2 Molecular genetics and target site specificity of retroviral integration
Holmes-Son, M. L., Appa, R. S., & Chow, S. A. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)43003-3 · Cited by 57
“Structural analysis of the core of HIV-1 and ASV integrases showed them to be dimers (Bujacz et al., 1996a; Bujacz et al., 1996b; Bujacz et al., 1995; Dyda et al., 1995), as did the N- and C-terminal domains of HIV-1 integrase (Eijkelenboom et al.”
BackgroundInfluentialReverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription
Warren, K., Warrilow, D., Meredith, L. W., & Harrich, D. (2009) · Viruses · doi:10.3390/v1030873 · Cited by 62
Design of Cell-Permeable Stapled Peptides as HIV-1 Integrase Inhibitors
Long, Y., Huang, S.-X., Zawahir, Z., Xu, Z.-L., Li, H., Sanchez, T. W., Zhi, Y., Houwer, S. D., Christ, F., Debyser, Z., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4006516 · Cited by 52
Inhibitors of Nucleotidyltransferase Superfamily Enzymes Suppress Herpes Simplex Virus Replication
Tavis, J. E., Wang, H., Tollefson, A. E., Ying, B., Korom, M., Cheng, X., Cao, F., Davis, K. L., Wold, W. S. M., & Morrison, L. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03875-14 · Cited by 53
“NTS enzymes include Escherichia coli RNase H 1 and 2 (30, 31), human RNase H 1 and 2 (32, 33), the RuvC Holliday junction resolvase (34), the Argonaute RNase (35), the hepatitis B virus (HBV) RNase H (36–38), the HIV RNase H (39), and the HIV integrase (40).”
BackgroundChon, H., Matsumura, H., Koga, Y., Takano, K., & Kanaya, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.017 · Cited by 48
Chemical Mechanisms for Mobilizing DNA
Mizuuchi, K., & Baker, T. A. (2007) · Wiley eBooks · doi:10.1128/9781555817954.ch2 · Cited by 49
HIV-1 Integrase Multimerization as a Therapeutic Target
Feng, L., Larue, R. C., Slaughter, A., Kessl, J. J., & Kvaratskhelia, M. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_439 · Cited by 45
“The CCD–CCD interactions are conserved in the CCD only structures (Dyda et al. 1994; Jenkins et al. 1995; Bujacz et al. 1996; Goldgur et al. 1998; Maignan et al. 1998) as well as in the both two domain NTD–CCD and CCD– CTD structures (Wang et al. 2001; Chen et al. 2000).”
BackgroundInfluentialStructural Folds of Viral Proteins
Chapman, M. S., & Liljas, L. (2003) · Advances in protein chemistry · doi:10.1016/s0065-3233(03)01004-0 · Cited by 50
Brigo, A., Lee, K. W., Mustata, G. I., & Briggs, J. M. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.050286 · Cited by 48
“The catalytic core domain of HIV-1, simian immunodeficiency virus, and Rous sarcoma virus integrases have been determined by x-ray crystallography as a single domain dimer (Bujacz et al., 1995, 1996; Dyda et al., 1994; Goldgur et al., 1998) and together with the N-terminal (Wang et al., 2001) or C-terminal (Chen et al…”
BackgroundResultInfluentialRecognition and Inhibition of HIV Integrase by Novel Dinucleotides
Taktakishvili, M., Neamati, N., Pommier, Y. G., Pal, S., & Nair, V. (2000) · Journal of the American Chemical Society · doi:10.1021/ja992528d · Cited by 45
Harper, A. L., Skinner, L. M., Sudol, M., & Katzman, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7756-7762.2001 · Cited by 45
“These sites are within or near a disordered, flexible surface loop that extends from residue 141 approximately to residue 150 (6).”
BackgroundHIV integrase as a target for antiviral chemotherapy
Nair, V. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.350 · Cited by 49
“Stereostructural representation of a ribbon model of the core domain of HIV-1 integrase based on crystal structure data [12].”
Mohammed, K. D., Topper, M. B., & Muesing, M. A. (2011) · Journal of Virology · doi:10.1128/jvi.02374-10 · Cited by 44
“The structural data show that the isoleucine residue at position 268 is the last residue of the fifth and final -sheet (residues 265 to 268) of the SH3 fold (13, 22, 23).”
BackgroundThe emerging diversity of transpososome architectures
Dyda, F., Chandler, M., & Hickman, A. B. (2012) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583512000145 · Cited by 49
“Retroviral integration also relies on enzymes that possess RNaseH-like catalytic domains (Dyda et al. 1994).”
BackgroundSelf-citationJohnson, B. C., Métifiot, M., Pommier, Y. G., & Hughes, S. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05292-11 · Cited by 48
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H
Wu, B., Tang, J. Y., Wilson, D. J., Huber, A. D., Casey, M. C., Ji, J., Kankanala, J., Xie, J., Sarafianos, S. G., & Wang, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00040 · Cited by 44
“4-Amino-N-benzyl-1-(hydroxy)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5carboxamide (46)—White solid, 89% yield; 1H NMR (600 MHz, DMSO-d6): δ 11.”
Corona, A., Leva, F. S. D., Rigogliuso, G., Pescatori, L., Madia, V. N., Subra, F., Delelis, O., Esposito, F., Cadeddu, M., Costi, R., et al. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.09.008 · Cited by 45
Single-particle Image Reconstruction of a Tetramer of HIV Integrase Bound to DNA
Ren, G., Gao, K., Bushman, F. D., & Yeager, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.029 · Cited by 53
Tchertanov, L., & Mouscadet, J. F. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061375j · Cited by 46
Update on computer-aided drug design
Jackson, R. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80106-5 · Cited by 44
Bera, S., Pandey, K. K., Vora, A. C., & Grandgenett, D. P. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.007 · Cited by 43
Shkriabai, N., Patil, S. S., Hess, S., Budihas, S. R., Craigie, R., Burke, T. R., Le Grice, S. F. J., & Kvaratskhelia, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400873101 · Cited by 43
Self-citationBeall, E. L., & Rio, D. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2122 · Cited by 44
“The similarities have been extended to include members of the RNase H and Ruv C class of nucleases (Dyda et al., 1994; Bujacz et al., 1995, 1996; Rice and Mizuuchi, 1995; Rice et al., 1996).”
BackgroundQiu, X., & Janson, C. A. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904015422 · Cited by 43
“Eminent successes include the alkylation of lysines in myosin subfragment-1 (Rayment, 1997) and the Phe185Lys mutation in HIV integrase (Dyda et al., 1994).”
BackgroundHarper, A. L., Sudol, M., & Katzman, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.6.3838-3845.2003 · Cited by 43
“Boxes indicate the 4 strand, 2 helix, and 3 helix as defined in the original papers that described the HIV-1 and RSV crystal structures (4, 9).”
BackgroundEnhanced and coordinated processing of synapsed viral DNA ends by retroviral integrases in vitro.
Kukolj, G., & Skalka, A. M. (1995) · Genes & Development · doi:10.1101/gad.9.20.2556 · Cited by 46
Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications
Galeazzi, R. (2009) · Current Computer - Aided Drug Design · doi:10.2174/157340909789577847 · Cited by 42
Reddy, K. K., Singh, S. K., Dessalew, N., Tripathi, S. K., & Selvaraj, C. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.590803 · Cited by 42
Cai, M., Caffrey, M. S., Clore, G. M., Gronenborn, A. M., Huang, Y. K., Zheng, R., & Craigie, R. (1998) · Protein Science · doi:10.1002/pro.5560071221 · Cited by 47
Self-citationProgress in anti-HIV structure-based drug design
Gait, M. J., & Karn, J. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)88998-2 · Cited by 42
Recent Advances in the Discovery of Small-Molecule Inhibitors of HIV-1 Integrase
Choi, E., Mallareddy, J. R., Lu, D., & Kolluru, S. (2018) · Future Science OA · doi:10.4155/fsoa-2018-0060 · Cited by 51
Wielens, J., Headey, S. J., Jeevarajah, D., Rhodes, D. I., Deadman, J. J., Chalmers, D. K., Scanlon, M. J., & Parker, M. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.016 · Cited by 46
“The crystal structures of truncated IN proteins (INCORE [16–26], INCORE+C [19,27,28], INCORE+N [29,30]) have been determined but no structure of the full length enzyme or IN with viral DNA is available.”
BackgroundThe role of lysine 186 in HIV-1 integrase multimerization
Berthoux, L., Sebastian, S., Muesing, M. A., & Luban, J. (2007) · Virology · doi:10.1016/j.virol.2007.02.029 · Cited by 48
“The IN CCD domain, that contains the KRK motif, has been crystallized, either alone (Dyda et al., 1994) or with the CTD (Chen et al., 2000) or the NTD (Wang et al., 2001).”
BackgroundStrategies for Antiviral Drug Discovery
Jones, P. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900401 · Cited by 41
Stereospecificity of Reactions Catalyzed by HIV-1 Integrase
Gerton, J. L., Herschlag, D., & Brown, P. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33480 · Cited by 41
Brigo, A., Lee, K. W., Fogolari, F., Mustata, G. I., & Briggs, J. M. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20447 · Cited by 44
Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors
Jurado, K. A., & Engelman, A. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.15 · Cited by 40
Self-citationDeterminants for hairpin formation in Tn10 transposition
Allingham, J. S., Wardle, S. J., & Haniford, D. B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2931 · Cited by 40
HIV-I integrase inhibitors: Past, present, and future
Neamati, N., Marchand, C., & Pommier, Y. G. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)49026-5 · Cited by 48
Molecular docking, QPLD, and ADME prediction studies on HIV-1 integrase leads
Tripathi, S. K., Selvaraj, C., Singh, S. K., & Reddy, K. K. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9940-6 · Cited by 44
“catalytic domain of IN was determined by X-ray crystallography (Lodi et al., 1995; Cai et al., 1997; Eijkelenboom et al., 1995; Dyda et al., 1994; Bujacz et al., 1995).”
MethodArrays of Iso-Oriented Gold Nanobelts
Chen, Y., Milenković, S., & Hassel, A. W. (2008) · Nano Letters · doi:10.1021/nl0725852 · Cited by 40
Kirchner, J., & Sandmeyer, S. B. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4737-4747.1996 · Cited by 41
“IN has been expressed in a variant which has elevated solubility in vitro, and its crystal structure has been determined (21).”
BackgroundPresence of a Characteristic D-D-E Motif in IS1Transposase
Ohta, S., Tsuchida, K., Choi, S., Sekine, Y., Shiga, Y., & Ohtsubo, E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.22.6146-6154.2002 · Cited by 38
“been determined by X-ray crystallography (6, 9, 35).”
MethodAkasako-Furukawa, A., Haruki, M., Oobatake, M., & Kanaya, S. (1995) · Biochemistry · doi:10.1021/bi00025a018 · Cited by 38
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
Koh, Y., Matreyek, K. A., & Engelman, A. (2011) · Journal of Virology · doi:10.1128/jvi.02541-10 · Cited by 37
“IN belongs to the polynucleotidyl transferase superfamily of nucleic acid-metabolizing enzymes (7).”
BackgroundSelf-citationReddy, K. K., Singh, S. K., Tripathi, S. K., & Selvaraj, C. (2013) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2013.772919 · Cited by 40
“The CCD (amino acids 50– 212) contains the highly conserved Asp64, Asp116, and Glu152 (DDE) residues, and is directly involved in the catalytic activities of IN.”
BackgroundHIV-1 Integrase: From Biology to Chemotherapeutics
Loizidou, E. Z., Nicolaou, C. A., Nicolaides, A. V., & Kostrikis, L. G. (2007) · Current HIV Research · doi:10.2174/157016207781023965 · Cited by 43
Measuring rapid hydrogen exchange in the homodimeric 36 kDa HIV‐1 integrase catalytic core domain
Fitzkee, N. C., Torchia, D. A., & Bax, A. (2011) · Protein Science · doi:10.1002/pro.582 · Cited by 38
Katzman, M., & Sudol, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1744-1753.1998 · Cited by 41
“8; crystallographic data support this orientation for a dimer of the central regions whose monomers are related by a dyad axis (5, 15).”
BackgroundAlian, A., Griner, S. L., Chiang, V., Tsiang, M., Jones, G., Birkus, G., Geleziunas, R., Leavitt, A. D., & Stroud, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811919106 · Cited by 36
“The 2 IN active sites lie on opposite sides of the IN dimer (17, 18, 26) such that DNA binding to 1 active site would not occlude the other site from binding a second DNA.”
BackgroundStructural and Functional Role of INI1 and LEDGF in the HIV-1 Preintegration Complex
Maillot, B., Lévy, N., Eiler, S., Crucifix, C., Granger, F., Richert, L., Didier, P., Godet, J., Pradeau‐Aubreton, K., Emiliani, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060734 · Cited by 56
Synthesis of novel flavonoid derivatives as potential HIV‐ Integrase inhibitors
Mateeva, N. N., Kode, R. N., & Redda, K. K. (2002) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570390620 · Cited by 36
Klarmann, G. J., Me, H., & Grice, S. F. J. L. (2002) · PubMed · Cited by 38
King, P. J., Lee, D. J., Reinke, R., Victoria, J. G., Beale, K. K., & Robinson, W. E. (2003) · Virology · doi:10.1016/s0042-6822(02)00042-9 · Cited by 37
Appa, R. S., Shin, C., Lee, P., & Chow, S. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107365200 · Cited by 38
Molecular dynamics studies of the full-length integrase–DNA complex
Luca, L. D., Vistoli, G., Pedretti, A., Barreca, M. L., & Chimirri, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.211 · Cited by 42
Reexamining AIDS research priorities
Paul, W. E. (1995) · Science · doi:10.1126/science.7839138 · Cited by 36
Ronning, D. R., Li, Y., Perez, Z. N., Ross, P. D., Hickman, A. B., Craig, N. L., & Dyda, F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600311 · Cited by 34
“In contrast, sequence similarity and identification of the active site residues (Sarnovsky et al, 1996) indicate that TnsB is a member of the polynucleotidyl transferase superfamily defined by the core domain of HIV-1 integrase (Dyda et al, 1994).”
BackgroundSelf-citationMultimodal Functionalities of HIV-1 Integrase
Engelman, A., & Kvaratskhelia, M. (2022) · Viruses · doi:10.3390/v14050926 · Cited by 41
“All three Pol protein domains, PR [237], RT [238], and IN [72,73,76,80], function as obligate enzyme multimers, and the IN domain, possibly in con-”
BackgroundSelf-citationLi, H.-Y., Zawahir, Z., Song, L.-D., Long, Y., & Neamati, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060307u · Cited by 36
Mapping DNA‐binding sites of HIV‐1 integrase by protein footprinting
Dirac, A. M. G., & Kjems, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01932.x · Cited by 34
A high-throughput assay for Tn5 Tnp-induced DNA cleavage
Ason, B. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh080 · Cited by 34
Shkriabai, N., Dharmarajan, V., Slaughter, A., Kessl, J. J., Larue, R. C., Feng, L., Fuchs, J. R., Griffin, P. R., & Kvaratskhelia, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589572 · Cited by 30
HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination
Nishana, M., Nilavar, N. M., Kumari, R., Pandey, M., & Raghavan, S. C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.237 · Cited by 33
“aspartic acid residues relative to these elements are also comparable between RAG1 and integrase.(8,9) Besides, there”
BackgroundRetroviral cDNA Integration: Mechanism, Applications and Inhibition
Hansen, M. S. T., Carteau, S., Hoffmann, C. J., Li, L., & Bushman, F. D. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1739-3_3 · Cited by 37
Wlodawer, A. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60305-x · Cited by 40
Patterns of resistance development with integrase inhibitors in HIV
Cane, P., Mbisa, J. L., & Martín (2011) · Infection and Drug Resistance · doi:10.2147/idr.s7775 · Cited by 41
Tsunaka, Y., Takano, K., Matsumura, H., Yamagata, Y., & Kanaya, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.007 · Cited by 36
Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited
Tang, J. Y., Maddali, K., Pommier, Y. G., Sham, Y. Y., & Wang, Z. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.048 · Cited by 33
Reddy, K. K., Singh, P. C., & Singh, S. K. (2013) · Molecular BioSystems · doi:10.1039/c3mb70418a · Cited by 34
Inhibitor design by wrapping packing defects in HIV-1 proteins
Fernández, A., Rogale, K., Scott, R., & Scheraga, H. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404641101 · Cited by 31
Dreyfus, D. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005778 · Cited by 32
“RAG-1 and RISC both utilize magnesium ions in a site functionally related to the DDE site of RNAse H, also shared with retroviral integrases [25,26].”
BackgroundHIV-1 integrase interacts with yeast microtubule-associated proteins
de Soultrait, V. R., Caumont‐Sarcos, A., Durrens, P., Calmels, C., Parissi, V., Recordon-Pinson, P., Bon, E., Desjobert, C., Tarrago‐Litvak, L., & Fournier, M. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00241-5 · Cited by 37
Reactivity of selenomethionin – dents in the magic bullet?
Smith, J. L., & Thompson, A. (1998) · Structure · doi:10.1016/s0969-2126(98)00083-5 · Cited by 31
Current strategies in the treatment of HIV infection
Cohen, O. J., & Fauci, A. S. (2002) · Disease-a-Month · doi:10.1067/mda.2002.124659 · Cited by 30
Rousseau, P., Normand, C., Loot, C., Turlan, C., Alazard, R. J., Duval-Valentin, G., & Chandler, M. (2007) · doi:10.1128/9781555817954.ch16 · Cited by 31
Hoyte, A. C., Jamin, A. V., Koneru, P. C., Kobe, M. J., Larue, R. C., Fuchs, J. R., Engelman, A. N., & Kvaratskhelia, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.816645 · Cited by 30
“The CCD harbors an extensive dimerization interface (16), which is where LEDGF/p75 principally engages IN (17).”
BackgroundMethodSelf-citationPotentials of phenolic molecules of natural origin and their derivatives as anti-HIV agents
Khan, M. T. H., & Ather, A. (2007) · Biotechnology annual review · doi:10.1016/s1387-2656(07)13009-x · Cited by 30
Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors
Reddy, K. K., & Singh, S. K. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.011 · Cited by 32
In Search of Authentic Inhibitors of HIV-1 Integration
Debyser, Z., Cherepanov, P., Maele, B. V., Clercq, E. D., & Witvrouw, M. (2002) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020201300101 · Cited by 31
“The structure of the core in this Y-shaped dimer was identical to the structure resolved by Dyda et al. (1994).”
BackgroundAtwood, A., Choi, J., & Levin, H. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1324-1333.1998 · Cited by 29
“The IN proteins of human immunodeficiency virus (HIV), Moloney murine leukemia virus, Rous sarcoma virus, and Ty1 have been purified and were found in in vitro reactions with model substrates to be sufficient for strand transfer activity (6, 9, 23, 38).”
BackgroundInfluentialRefined solution structure of the dimeric N-terminal HHCC domain of HIV-2 integrase
Eijkelenboom, A. P. A. M., van den Ent, F. M. I., Wechselberger, R. W., Plasterk, R. H. A., Kaptein, R., & Boelens, R. (2000) · Journal of Biomolecular NMR · doi:10.1023/a:1008342312269 · Cited by 31
“X-ray structures of the dimeric catalytic core domain of HIV IN (Dyda et al., 1994; Goldgur et al., 1998; Maignan et al., 1998) and Avian Sarcoma Virus IN (Bujacz et al., 1995; Bujacz et al., 1996) have been determined in the presence and absence of metal cofactors.”
BackgroundBojja, R. S., Andrake, M. D., Weigand, S., Merkel, G., Yarychkivska, O., Henderson, A., Kummerling, M., & Skalka, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212571 · Cited by 29
Analysis of the DDE Motif in the Mutator Superfamily
Hua‐Van, A., & Capy, P. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9178-1 · Cited by 31
“The conserved domain 1, made of three b-sheets, followed by a short a-helix and another b-sheet, has the typical structure found in other prokaryotic or eukaryotic DDE domains (HIV, Tn5, Hermes, or Mos1 [Davies et al. 2000; Dyda et al. 1994; Hickman et al. 2005; Richardson et al. 2006]).”
BackgroundTaddeo, B., Carlini, F., Verani, P., & Engelman, A. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8277-8284.1996 · Cited by 29
“(B) Dimer in the crystal, showing parts of a1, a3, a5, a6, and b3, which form the dimer interface (17).”
BackgroundInfluentialSelf-citationThe core domain of retrotransposon integrase in Hordeum: predicted structure and evolution
Suoniemi, A., Tanskanen, J., Pentikäinen, O. T., Johnson, M. S., & Schulman, A. H. (1998) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026021 · Cited by 29
“…and bacterial IS elements (Kulkosky et al. 1992; Baker and Luo 1994), and the similarity of the crystal structures of retroviral IN catalytic domains (Dyda et al. 1994; Bujacz et al. 1995) and the Mu transposase core (Rice and Mizuuchi 1995) to RNase H and to Escherichia coli RuvC places these…”
BackgroundInfluentialChen, I., Neamati, N., Nicklaus, M. C., Orr, A., Anderson, L., Barchi, J. J., Kelley, J. A., Pommier, Y. G., & MacKerell, A. D. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00180-2 · Cited by 31
Advances in the development of HIV integrase strand transfer inhibitors
Wang, Y., Gu, S., He, Q., & Fan, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113787 · Cited by 29
Gao, K., Wong, S. C., & Bushman, F. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6715-6722.2004 · Cited by 31
Retroviral Integrase: Then and Now
Andrake, M., & Skalka, A. M. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055043 · Cited by 38
Walker, M. A., Johnson, T., Ma, Z., Banville, J., Rémillard, R., Kim, O., Zhang, Y., Staab, A. J., Wong, H., Torri, A., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.010 · Cited by 28
Rapid experimental SAD phasing and hot-spot identification with halogenated fragments
Bauman, J. D., Harrison, J. J. E. K., & Arnold, E. (2015) · IUCrJ · doi:10.1107/s2052252515021259 · Cited by 29
Patel, D., Antwi, J., Koneru, P. C., Serrao, E., Forli, S., Kessl, J. J., Feng, L., Deng, N., Levy, R. M., Fuchs, J. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753384 · Cited by 30
“using the previously described crystallization condition (36).”
Self-citationFunctional domains of the IS1 transposase: analysis in vivo and in vitro
Ton‐Hoang, B., Turlan, C., & Chandler, M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04223.x · Cited by 32
“In the available crystal structures, a five-stranded bsheet (b1–5) is surrounded by six a helices (a1–6) with the two aspartate residues (D) located near b1 and b4 (Dyda et al., 1994; Rice et al., 1996) (Fig.”
Tobiason, D. M., Buchner, J. M., Thiel, W. H., Gernert, K. M., & Karls, A. C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02276.x · Cited by 28
“The first aspartic acid of the DDE-motif is within b1, the second aspartic acid is at the end of b4, and the glutamic acid is at the amino-terminal end of a4 (for a review, see Haren et al., 1999).”
BackgroundMethodInfluential
Metadata
- Authors
- Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1994-12-23
- Volume
- 266
- Issue
- 5193
- Pages
- 1981-1986
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2006572311
- Cited by
- 810
- References
- 73
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 27 · 2014: 27 · 2013: 28 · 2012: 19
- FWCI
- 39.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 integrase, catalytic domain, crystal structure, RNase H, RuvC, Holliday junction resolvase, viral DNA integration, HIV replication
- MeSH terms
- Amino Acid Sequence, Binding Sites, Crystallization, DNA Nucleotidyltransferases, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Solubility, HIV-1, Virus Integration, Ribonuclease H, Protein Structure, Secondary, Protein Folding, Crystallography, X-Ray, Integrases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.